Nicoya is one of four Canadian companies that was selected to receive a grant through the National Research Council of Canada Industrial Research Assistance Program.<\/p>\n
They received over $290,000 to fight current and future outbreaks of COVID-19.<\/p>\n
With this funding, they are working to develop a saliva-based test called 'Atlas'. Upon its development, it will be able to detect viral infections in real-time, allowing for testing to take place outside of labs, hospitals, and clinics.<\/p>\n
The company'sgoal is to produce lab-quality test results to an app in under 20 minutes.<\/p>\n
The test will be more accessible and affordable for everyone, as it eliminates the need for complex and expensive equipment.<\/p>\n
Those who use the test will have the option to share individual test results with public health databases to allow for seamless infection tracking and tracing in communities.<\/p>\n
Nicoya is working to make the testing process versatile as well. With a goal to test for both active and prior viral infections.<\/p>\n
They are hoping to meet the testing needs for COVID-19 and any future pandemics.<\/p>\n<\/p>\n
<\/p>\n
The rest is here:<\/p>\n
Kitchener based nanotechnology company receives over $290K in funding for COVID-19 fight - KitchenerToday.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Nicoya is one of four Canadian companies that was selected to receive a grant through the National Research Council of Canada Industrial Research Assistance Program. They received over $290,000 to fight current and future outbreaks of COVID-19. With this funding, they are working to develop a saliva-based test called 'Atlas' Continue reading